Tadalafil vs Topiramate: side-by-side comparison
Tadalafil (PDE5 inhibitor) and Topiramate (Antiepileptic (sulfamate-substituted monosaccharide)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Tadalafil | Topiramate |
|---|---|---|
| Therapeutic class | PDE5 inhibitor | Antiepileptic (sulfamate-substituted monosaccharide) |
| CAS | 171596-29-5 | 97240-79-4 |
| ATC | G04BE08 | N03AX11 |
| Molecular weight | 389.4 g/mol | 339.36 g/mol |
| Brands with this active ingredient | 7 | 1 |
What they share
Tadalafil and Topiramate share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Tadalafil acts by a different mechanism than Topiramate, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Tadalafil: Tadalafil selectively inhibits PDE5, the enzyme responsible for breaking down cyclic guanosine monophosphate in the corpus cavernosum and other vascular smooth muscle. Topiramate: Topiramate is a sulfamate-substituted monosaccharide with multiple mechanisms of action: blockade of voltage-gated sodium channels, enhancement of gamma-aminobutyric acid (GABA) activity at non-benzodiazepine GABA-A rece…
Indications compared
Tadalafil: Tadalafil is approved for three indications: erectile dysfunction in adult men, lower urinary tract symptoms associated with benign prostatic hyperplasia, and pulmonary arterial hypertension. Topiramate: Topiramate is approved in adults and children for the treatment of partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome (as adjunctive or monotherapy depe…
Safety profile
Tadalafil: Common adverse effects in clinical trials include headache, dyspepsia, back pain, myalgia, nasal congestion and facial flushing. Topiramate: Common adverse effects include paraesthesia, fatigue, dizziness, anorexia and weight loss, and cognitive symptoms (word-finding difficulties, concentration problems).
Frequently asked questions
Is Tadalafil better than Topiramate? ▾
Tadalafil and Topiramate are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Tadalafil and Topiramate be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Tadalafil
Products with Topiramate
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.